Navigating barriers: new program aims to boost cervical cancer screening in senegal

NCT ID NCT05544084

Recruiting now Prevention Sponsor: University of Illinois at Chicago Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a patient navigation program to help women in Senegal overcome barriers to cervical cancer screening and follow-up care. Researchers will work with community health workers to guide women through the process, addressing stigma and misinformation. The goal is to increase screening rates and reduce deaths from cervical cancer in both urban and rural areas.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Patient Navigator Approach (behavioral intervention)
What this could lead to: If successful, this could provide a proven way to increase cervical cancer screening and reduce deaths in Senegal and similar countries.
What could go wrong: This is an implementation study, not a drug trial, so it won't directly test a new treatment. Results may vary by region and depend on local resources and participation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BEHAVIOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior cervical cancer Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BEHAVIOR CERVICAL CANCER

Contacts and locations

Locations

University of Cheikh Anta Diop, Institute of Health and Development
RECRUITING

Dakar, Senegal

More trials for these conditions

Other studies related to the condition(s) this trial covers.